Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

View source ↗

Summary

This completed study reports the discovery of novel biomarkers that could enable earlier detection of Alzheimer's disease, potentially before symptoms appear.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baylor Research Institute | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Status: COMPLETED